Kalvista Pharmaceuticals Inc (KALV) — Cash Flow Reinvestment Rate

Latest as of January 2018: 0.01x

Kalvista Pharmaceuticals Inc (KALV) has a Cash Flow Reinvestment Rate of 0.01x as of January 2018, reinvesting $182.00K (capex $182.00K ) from operating cash flow of $28.22 Million. Explore Kalvista Pharmaceuticals Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.01x
(Capex + Investments) / Operating CF

Total Reinvested

$182.00K
Capex + Investments

Operating Cash Flow

$28.22 Million
USD

Capital Expenditures

$182.00K
USD

Kalvista Pharmaceuticals Inc Cash Flow Reinvestment Rate (2018–2018)

Historical reinvestment intensity for Kalvista Pharmaceuticals Inc across 1 annual periods. Also explore KALV total asset value for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Kalvista Pharmaceuticals Inc (2018–2018)

Year-by-year capital reinvestment analysis for Kalvista Pharmaceuticals Inc. For live market cap and broader valuation context, see KALV company net worth.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2018 0.27x $2.85 Million $10.56 Million $1.43 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow